No. 11989 8cf49e [Reply] report 
ZELENKO PROTOCOL WITH DOSAGES
https://www.quora.com/?pa_story=MTQzMzIxMTM5OTcyNTU0MjExNHwyMTExMDYyMzUzNzc5NDB8MA**

Low risk patients
    Supportive care with fluids, fever control, and rest
    Elemental Zinc 50mg 1 time a day for 7 days
    Vitamin C 1000mg 1 time a day for 7 days
    Vitamin D3 5000iu 1 time a day for 7 days

Optional over the counter options
    Quercetin 500mg 2 times a day for 7 days or
    Epigallocatechin-gallate (EGCG) 400mg 1 time a day for 7 days


Moderate / High risk patients
    Elemental Zinc 50-100mg once a day for 7 days
    Vitamin C 1000mg 1 time a day for 7 days
    Vitamin D3 10000iu once a day for 7 days or 50000iu once a day for 1-2 days
    Azithromycin 500mg 1 time a day for 5 days or
    Doxycycline 100mg 2 times a day for 7 days
    Hydroxychloroquine (HCQ) 200mg 2 times a day for 5-7 days and/or
    Ivermectin 0.4-0.5mg/kg/day for 5-7 days Either or both HCQ and IVM can be used, and if one only, the second agent may be added after about 2 days of treatment if obvious recovery has not yet been observed etc.

Treatment Options
    Dexamethasone 6-12mg 1 time a day for 7 days or
    Prednisone 20mg twice a day for 7 days, taper as needed
    Budesonide 1mg/2cc solution via nebulizer twice a day for 7 days
    Blood thinners (i.e. Lovenox, Eliquis, Xarelto, Pradaxa, Aspirin)
    Colchicine 0.6mg 2-3 times a day for 5-7 days
    Monoclonal antibodies
    Home IV fluids and oxygen


TRY TO KEEP PATIENTS OUT OF THE HOSPITAL

    https://www.sciencedirect.com/science/article/pii/S0924857920304258
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7365891/
    https://pubs.acs.org/doi/10.1021/jf5014633
    https://vdmeta.com/
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318306/
    https://pubs.acs.org/doi/10.1021/jf5014633
    https://www.sciencedirect.com/science/article/pii/S0924857920304258
    https://ivmmeta.com/
    https://www.nejm.org/doi/full/10.1056/NEJMoa2021436
    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392554/
    https://www.medrxiv.org/content/10.1101/2021.01.26.21250494v1